You just read:

WeissLaw LLP: Unilens Vision, Inc. Acquisition By Valeant Pharmaceuticals International, Inc. May Not Be In The Best Interest Of UVIC Shareholders

News provided by

WeissLaw LLP

Jul 20, 2015, 02:00 ET